Mitochondrial tRNAThr 15909A>G mutation associated with hypertension in a Chinese Han pedigree

Haiying Li1, Junwei Geng2, Han Yu2

  • 1Department of Cardiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China; Department of Cardiology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.

Insights

A mitochondrial DNA mutation in tRNAThr was linked to maternally inherited hypertension in a Chinese Han family. This genetic variant impairs mitochondrial function, potentially contributing to hypertension development.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cardiovascular Disease

Background:

  • Mitochondrial DNA (mtDNA) mutations are implicated in the pathogenesis of hypertension.
  • Understanding the genetic underpinnings of inherited hypertension is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the clinical, genetic, and molecular basis of maternally inherited hypertension in a Chinese Han family.
  • To identify and characterize novel mtDNA mutations associated with hypertension.

Main Methods:

  • Clinical evaluation, genetic analysis, and mutational profiling of a multi-generational Chinese Han family.
  • Molecular characterization and biochemical assays to assess the impact of identified mtDNA variants on mitochondrial function.

Main Results:

  • A specific variant, m.15909A>G, in the mitochondrial tRNAThr gene was identified in affected individuals.
  • This mutation disrupts a conserved base pairing in the D-stem of tRNAThr, impairing its structure and function.
  • The mutation led to decreased mitochondrial protein synthesis, reduced Complex activity, diminished ATP production, and increased reactive oxygen species (ROS) generation.

Conclusions:

  • The m.15909A>G mtDNA mutation is a potential inherited factor contributing to hypertension in this Chinese Han pedigree.
  • mtDNA mutations affecting mitochondrial function represent a significant, yet often overlooked, genetic basis for hypertension.

Related Concept Videos

Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
157.5K
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
18.2K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.3K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
24
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
540
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
30.4K